 | • レポートコード：GIR-105X14209 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型サイトカイン治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型サイトカイン治療薬の種類別市場規模（インターフェロン、遺伝子組換え型ヒト顆粒球コロニー刺激因子、エリスロポエチン（EPO）、遺伝子組換え型ヒトトロンボポエチン、その他）、用途別市場規模（B型肝炎、C型肝炎、多発性硬化症、腫瘍治療、創傷治癒、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型サイトカイン治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Merck、Bayer、Biogen Idec、Gensci、Huaxin、Triprime、Sinovac、Zhaoke、Kawin、Abcam plc、R&D Systems、Thermo Fisher Scientific、BioLegend、Invitrogen、OriGene、Biorbyt、Qilu Pharmaceutical、Shijiazhuang Pharmaceutical、Amgen、Johnson & Johnson、Kyowa Hakko Kirin ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インターフェロン、遺伝子組換え型ヒト顆粒球コロニー刺激因子、エリスロポエチン（EPO）、遺伝子組換え型ヒトトロンボポエチン、その他 ・用途別分析2016年-2026年：B型肝炎、C型肝炎、多発性硬化症、腫瘍治療、創傷治癒、その他 ・遺伝子組換え型サイトカイン治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型サイトカイン治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型サイトカイン治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型サイトカイン治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型サイトカイン治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Cytokines Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Cytokines Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Cytokines Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Cytokines Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Interferon
Recombinant Human Granulocyte Colony-Stimulating
Erythropoietin (EPO)
Recombinant Human Thrombopoietin
Others
Market segment by Application can be divided into
Hepatitis B
Hepatitis C
Multiple Sclerosis
Tumor Therapy
Wound Healing
Others
The key market players for global Recombinant Cytokines Drug market are listed below:
Roche
Merck
Bayer
Biogen Idec
Gensci
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Abcam plc
R&D Systems
Thermo Fisher Scientific
BioLegend
Invitrogen
OriGene
Biorbyt
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Cytokines Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Cytokines Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Interferon
1.2.3 Recombinant Human Granulocyte Colony-Stimulating
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Human Thrombopoietin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Cytokines Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hepatitis B
1.3.3 Hepatitis C
1.3.4 Multiple Sclerosis
1.3.5 Tumor Therapy
1.3.6 Wound Healing
1.3.7 Others
1.4 Global Recombinant Cytokines Drug Market Size & Forecast
1.4.1 Global Recombinant Cytokines Drug Sales in Value (2016-2026))
1.4.2 Global Recombinant Cytokines Drug Sales in Volume (2016-2026)
1.4.3 Global Recombinant Cytokines Drug Price by Type (2016-2026) & (USD/g)
1.5 Global Recombinant Cytokines Drug Production Capacity Analysis
1.5.1 Global Recombinant Cytokines Drug Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Cytokines Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Cytokines Drug Market Drivers
1.6.2 Recombinant Cytokines Drug Market Restraints
1.6.3 Recombinant Cytokines Drug Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Recombinant Cytokines Drug Product and Services
2.1.4 Roche Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Recombinant Cytokines Drug Product and Services
2.2.4 Merck Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Recombinant Cytokines Drug Product and Services
2.3.4 Bayer Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biogen Idec
2.4.1 Biogen Idec Details
2.4.2 Biogen Idec Major Business
2.4.3 Biogen Idec Recombinant Cytokines Drug Product and Services
2.4.4 Biogen Idec Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Gensci
2.5.1 Gensci Details
2.5.2 Gensci Major Business
2.5.3 Gensci Recombinant Cytokines Drug Product and Services
2.5.4 Gensci Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Huaxin
2.6.1 Huaxin Details
2.6.2 Huaxin Major Business
2.6.3 Huaxin Recombinant Cytokines Drug Product and Services
2.6.4 Huaxin Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Triprime
2.7.1 Triprime Details
2.7.2 Triprime Major Business
2.7.3 Triprime Recombinant Cytokines Drug Product and Services
2.7.4 Triprime Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Recombinant Cytokines Drug Product and Services
2.8.4 Sinovac Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Zhaoke
2.9.1 Zhaoke Details
2.9.2 Zhaoke Major Business
2.9.3 Zhaoke Recombinant Cytokines Drug Product and Services
2.9.4 Zhaoke Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Kawin
2.10.1 Kawin Details
2.10.2 Kawin Major Business
2.10.3 Kawin Recombinant Cytokines Drug Product and Services
2.10.4 Kawin Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Abcam plc
2.11.1 Abcam plc Details
2.11.2 Abcam plc Major Business
2.11.3 Abcam plc Recombinant Cytokines Drug Product and Services
2.11.4 Abcam plc Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 R&D Systems
2.12.1 R&D Systems Details
2.12.2 R&D Systems Major Business
2.12.3 R&D Systems Recombinant Cytokines Drug Product and Services
2.12.4 R&D Systems Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business
2.13.3 Thermo Fisher Scientific Recombinant Cytokines Drug Product and Services
2.13.4 Thermo Fisher Scientific Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 BioLegend
2.14.1 BioLegend Details
2.14.2 BioLegend Major Business
2.14.3 BioLegend Recombinant Cytokines Drug Product and Services
2.14.4 BioLegend Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Invitrogen
2.15.1 Invitrogen Details
2.15.2 Invitrogen Major Business
2.15.3 Invitrogen Recombinant Cytokines Drug Product and Services
2.15.4 Invitrogen Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 OriGene
2.16.1 OriGene Details
2.16.2 OriGene Major Business
2.16.3 OriGene Recombinant Cytokines Drug Product and Services
2.16.4 OriGene Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Biorbyt
2.17.1 Biorbyt Details
2.17.2 Biorbyt Major Business
2.17.3 Biorbyt Recombinant Cytokines Drug Product and Services
2.17.4 Biorbyt Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Qilu Pharmaceutical
2.18.1 Qilu Pharmaceutical Details
2.18.2 Qilu Pharmaceutical Major Business
2.18.3 Qilu Pharmaceutical Recombinant Cytokines Drug Product and Services
2.18.4 Qilu Pharmaceutical Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Shijiazhuang Pharmaceutical
2.19.1 Shijiazhuang Pharmaceutical Details
2.19.2 Shijiazhuang Pharmaceutical Major Business
2.19.3 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Product and Services
2.19.4 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Amgen
2.20.1 Amgen Details
2.20.2 Amgen Major Business
2.20.3 Amgen Recombinant Cytokines Drug Product and Services
2.20.4 Amgen Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Johnson & Johnson
2.21.1 Johnson & Johnson Details
2.21.2 Johnson & Johnson Major Business
2.21.3 Johnson & Johnson Recombinant Cytokines Drug Product and Services
2.21.4 Johnson & Johnson Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Kyowa Hakko Kirin
2.22.1 Kyowa Hakko Kirin Details
2.22.2 Kyowa Hakko Kirin Major Business
2.22.3 Kyowa Hakko Kirin Recombinant Cytokines Drug Product and Services
2.22.4 Kyowa Hakko Kirin Recombinant Cytokines Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Cytokines Drug Sales by Manufacturer
3.1 Global Recombinant Cytokines Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Cytokines Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Cytokines Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Cytokines Drug Manufacturer Market Share
3.4.2 Top 6 Recombinant Cytokines Drug Manufacturer Market Share
3.5 Global Recombinant Cytokines Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Cytokines Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Cytokines Drug Market Size by Region
4.1.1 Global Recombinant Cytokines Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Cytokines Drug Revenue by Region (2016-2026)
4.2 North America Recombinant Cytokines Drug Revenue (2016-2026)
4.3 Europe Recombinant Cytokines Drug Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Cytokines Drug Revenue (2016-2026)
4.5 South America Recombinant Cytokines Drug Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Cytokines Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Cytokines Drug Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Cytokines Drug Revenue by Type (2016-2026)
5.3 Global Recombinant Cytokines Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Cytokines Drug Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Cytokines Drug Revenue by Application (2016-2026)
6.3 Global Recombinant Cytokines Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Cytokines Drug Sales by Type (2016-2026)
7.2 North America Recombinant Cytokines Drug Sales by Application (2016-2026)
7.3 North America Recombinant Cytokines Drug Market Size by Country
7.3.1 North America Recombinant Cytokines Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Cytokines Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Cytokines Drug Sales by Type (2016-2026)
8.2 Europe Recombinant Cytokines Drug Sales by Application (2016-2026)
8.3 Europe Recombinant Cytokines Drug Market Size by Country
8.3.1 Europe Recombinant Cytokines Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Cytokines Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Cytokines Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Cytokines Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Cytokines Drug Market Size by Region
9.3.1 Asia-Pacific Recombinant Cytokines Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Cytokines Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Cytokines Drug Sales by Type (2016-2026)
10.2 South America Recombinant Cytokines Drug Sales by Application (2016-2026)
10.3 South America Recombinant Cytokines Drug Market Size by Country
10.3.1 South America Recombinant Cytokines Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Cytokines Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Cytokines Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Cytokines Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Cytokines Drug Market Size by Country
11.3.1 Middle East & Africa Recombinant Cytokines Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Cytokines Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Cytokines Drug Typical Distributors
12.3 Recombinant Cytokines Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Cytokines Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Cytokines Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Recombinant Cytokines Drug Product and Services
Table 6. Roche Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Recombinant Cytokines Drug Product and Services
Table 10. Merck Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Recombinant Cytokines Drug Product and Services
Table 14. Bayer Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 16. Biogen Idec Major Business
Table 17. Biogen Idec Recombinant Cytokines Drug Product and Services
Table 18. Biogen Idec Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Gensci Basic Information, Manufacturing Base and Competitors
Table 20. Gensci Major Business
Table 21. Gensci Recombinant Cytokines Drug Product and Services
Table 22. Gensci Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Huaxin Basic Information, Manufacturing Base and Competitors
Table 24. Huaxin Major Business
Table 25. Huaxin Recombinant Cytokines Drug Product and Services
Table 26. Huaxin Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Triprime Basic Information, Manufacturing Base and Competitors
Table 28. Triprime Major Business
Table 29. Triprime Recombinant Cytokines Drug Product and Services
Table 30. Triprime Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sinovac Basic Information, Manufacturing Base and Competitors
Table 32. Sinovac Major Business
Table 33. Sinovac Recombinant Cytokines Drug Product and Services
Table 34. Sinovac Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Zhaoke Basic Information, Manufacturing Base and Competitors
Table 36. Zhaoke Major Business
Table 37. Zhaoke Recombinant Cytokines Drug Product and Services
Table 38. Zhaoke Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kawin Basic Information, Manufacturing Base and Competitors
Table 40. Kawin Major Business
Table 41. Kawin Recombinant Cytokines Drug Product and Services
Table 42. Kawin Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Abcam plc Basic Information, Manufacturing Base and Competitors
Table 44. Abcam plc Major Business
Table 45. Abcam plc Recombinant Cytokines Drug Product and Services
Table 46. Abcam plc Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 48. R&D Systems Major Business
Table 49. R&D Systems Recombinant Cytokines Drug Product and Services
Table 50. R&D Systems Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 52. Thermo Fisher Scientific Major Business
Table 53. Thermo Fisher Scientific Recombinant Cytokines Drug Product and Services
Table 54. Thermo Fisher Scientific Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. BioLegend Basic Information, Manufacturing Base and Competitors
Table 56. BioLegend Major Business
Table 57. BioLegend Recombinant Cytokines Drug Product and Services
Table 58. BioLegend Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Invitrogen Basic Information, Manufacturing Base and Competitors
Table 60. Invitrogen Major Business
Table 61. Invitrogen Recombinant Cytokines Drug Product and Services
Table 62. Invitrogen Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. OriGene Basic Information, Manufacturing Base and Competitors
Table 64. OriGene Major Business
Table 65. OriGene Recombinant Cytokines Drug Product and Services
Table 66. OriGene Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 68. Biorbyt Major Business
Table 69. Biorbyt Recombinant Cytokines Drug Product and Services
Table 70. Biorbyt Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Qilu Pharmaceutical Major Business
Table 73. Qilu Pharmaceutical Recombinant Cytokines Drug Product and Services
Table 74. Qilu Pharmaceutical Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Shijiazhuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Shijiazhuang Pharmaceutical Major Business
Table 77. Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Product and Services
Table 78. Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Amgen Basic Information, Manufacturing Base and Competitors
Table 80. Amgen Major Business
Table 81. Amgen Recombinant Cytokines Drug Product and Services
Table 82. Amgen Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 84. Johnson & Johnson Major Business
Table 85. Johnson & Johnson Recombinant Cytokines Drug Product and Services
Table 86. Johnson & Johnson Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 88. Kyowa Hakko Kirin Major Business
Table 89. Kyowa Hakko Kirin Recombinant Cytokines Drug Product and Services
Table 90. Kyowa Hakko Kirin Recombinant Cytokines Drug Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Global Recombinant Cytokines Drug Sales by Manufacturer (2019-2021e) & (KG)
Table 92. Global Recombinant Cytokines Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 93. Market Position of Manufacturers in Recombinant Cytokines Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 94. Global Recombinant Cytokines Drug Production Capacity by Company, (KG): 2020 VS 2021
Table 95. Head Office and Recombinant Cytokines Drug Production Site of Key Manufacturer
Table 96. Global Recombinant Cytokines Drug Sales by Region (2016-2021e) & (KG)
Table 97. Global Recombinant Cytokines Drug Sales by Region (2021-2026) & (KG)
Table 98. Global Recombinant Cytokines Drug Revenue by Region (2016-2021e) & (USD Million)
Table 99. Global Recombinant Cytokines Drug Revenue by Region (2021-2026) & (USD Million)
Table 100. Global Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 101. Global Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 102. Global Recombinant Cytokines Drug Revenue by Type (2016-2021e) & (USD Million)
Table 103. Global Recombinant Cytokines Drug Revenue by Type (2021-2026) & (USD Million)
Table 104. Global Recombinant Cytokines Drug Price by Type (2016-2021e) & (USD/g)
Table 105. Global Recombinant Cytokines Drug Price by Type (2021-2026) & (USD/g)
Table 106. Global Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 107. Global Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 108. Global Recombinant Cytokines Drug Revenue by Application (2016-2021e) & (USD Million)
Table 109. Global Recombinant Cytokines Drug Revenue by Application (2021-2026) & (USD Million)
Table 110. Global Recombinant Cytokines Drug Price by Application (2016-2021e) & (USD/g)
Table 111. Global Recombinant Cytokines Drug Price by Application (2021-2026) & (USD/g)
Table 112. North America Recombinant Cytokines Drug Sales by Country (2016-2021e) & (KG)
Table 113. North America Recombinant Cytokines Drug Sales by Country (2021-2026) & (KG)
Table 114. North America Recombinant Cytokines Drug Revenue by Country (2016-2021e) & (USD Million)
Table 115. North America Recombinant Cytokines Drug Revenue by Country (2021-2026) & (USD Million)
Table 116. North America Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 117. North America Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 118. North America Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 119. North America Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 120. Europe Recombinant Cytokines Drug Sales by Country (2016-2021e) & (KG)
Table 121. Europe Recombinant Cytokines Drug Sales by Country (2021-2026) & (KG)
Table 122. Europe Recombinant Cytokines Drug Revenue by Country (2016-2021e) & (USD Million)
Table 123. Europe Recombinant Cytokines Drug Revenue by Country (2021-2026) & (USD Million)
Table 124. Europe Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 125. Europe Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 126. Europe Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 127. Europe Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 128. Asia-Pacific Recombinant Cytokines Drug Sales by Region (2016-2021e) & (KG)
Table 129. Asia-Pacific Recombinant Cytokines Drug Sales by Region (2021-2026) & (KG)
Table 130. Asia-Pacific Recombinant Cytokines Drug Revenue by Region (2016-2021e) & (USD Million)
Table 131. Asia-Pacific Recombinant Cytokines Drug Revenue by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 133. Asia-Pacific Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 134. Asia-Pacific Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 135. Asia-Pacific Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 136. South America Recombinant Cytokines Drug Sales by Country (2016-2021e) & (KG)
Table 137. South America Recombinant Cytokines Drug Sales by Country (2021-2026) & (KG)
Table 138. South America Recombinant Cytokines Drug Revenue by Country (2016-2021e) & (USD Million)
Table 139. South America Recombinant Cytokines Drug Revenue by Country (2021-2026) & (USD Million)
Table 140. South America Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 141. South America Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 142. South America Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 143. South America Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 144. Middle East & Africa Recombinant Cytokines Drug Sales by Country (2016-2021e) & (KG)
Table 145. Middle East & Africa Recombinant Cytokines Drug Sales by Country (2021-2026) & (KG)
Table 146. Middle East & Africa Recombinant Cytokines Drug Revenue by Country (2016-2021e) & (USD Million)
Table 147. Middle East & Africa Recombinant Cytokines Drug Revenue by Country (2021-2026) & (USD Million)
Table 148. Middle East & Africa Recombinant Cytokines Drug Sales by Type (2016-2021e) & (KG)
Table 149. Middle East & Africa Recombinant Cytokines Drug Sales by Type (2021-2026) & (KG)
Table 150. Middle East & Africa Recombinant Cytokines Drug Sales by Application (2016-2021e) & (KG)
Table 151. Middle East & Africa Recombinant Cytokines Drug Sales by Application (2021-2026) & (KG)
Table 152. Direct Channel Pros & Cons
Table 153. Indirect Channel Pros & Cons
Table 154. Recombinant Cytokines Drug Typical Distributors
Table 155. Recombinant Cytokines Drug Typical Customers
List of Figures
Figure 1. Recombinant Cytokines Drug Picture
Figure 2. Global Recombinant Cytokines Drug Sales Market Share by Type in 2020
Figure 3. Interferon
Figure 4. Recombinant Human Granulocyte Colony-Stimulating
Figure 5. Erythropoietin (EPO)
Figure 6. Recombinant Human Thrombopoietin
Figure 7. Others
Figure 8. Global Recombinant Cytokines Drug Sales Market Share by Application in 2020
Figure 9. Hepatitis B
Figure 10. Hepatitis C
Figure 11. Multiple Sclerosis
Figure 12. Tumor Therapy
Figure 13. Wound Healing
Figure 14. Others
Figure 15. Global Recombinant Cytokines Drug Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 16. Global Recombinant Cytokines Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Recombinant Cytokines Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Recombinant Cytokines Drug Sales (2016-2026) & (KG)
Figure 37. Global Recombinant Cytokines Drug Production Capacity (2016-2026) & (KG)
Figure 38. Global Recombinant Cytokines Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Recombinant Cytokines Drug Market Drivers
Figure 40. Recombinant Cytokines Drug Market Restraints
Figure 41. Recombinant Cytokines Drug Market Trends
Figure 42. Global Recombinant Cytokines Drug Sales Market Share by Manufacturer in 2020
Figure 43. Global Recombinant Cytokines Drug Revenue Market Share by Manufacturer in 2020
Figure 44. Recombinant Cytokines Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Recombinant Cytokines Drug Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Recombinant Cytokines Drug Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Recombinant Cytokines Drug Sales Market Share by Region (2016-2026)
Figure 48. Global Recombinant Cytokines Drug Revenue Market Share by Region (2016-2026)
Figure 49. North America Recombinant Cytokines Drug Revenue (2016-2026) & (USD Million)
Figure 50. Europe Recombinant Cytokines Drug Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Recombinant Cytokines Drug Revenue (2016-2026) & (USD Million)
Figure 52. South America Recombinant Cytokines Drug Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Recombinant Cytokines Drug Revenue (2016-2026) & (USD Million)
Figure 54. Global Recombinant Cytokines Drug Sales Market Share by Type (2016-2026)
Figure 55. Global Recombinant Cytokines Drug Revenue Market Share by Type (2016-2026)
Figure 56. Global Recombinant Cytokines Drug Price by Type (2016-2026) & (USD/g)
Figure 57. Global Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 58. Global Recombinant Cytokines Drug Revenue Market Share by Application (2016-2026)
Figure 59. Global Recombinant Cytokines Drug Price by Application (2016-2026) & (USD/g)
Figure 60. North America Recombinant Cytokines Drug Sales Market Share by Country (2016-2026)
Figure 61. North America Recombinant Cytokines Drug Revenue Market Share by Country (2016-2026)
Figure 62. North America Recombinant Cytokines Drug Sales Market Share by Type (2016-2026)
Figure 63. North America Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 64. Europe Recombinant Cytokines Drug Sales Market Share by Country (2016-2026)
Figure 65. Europe Recombinant Cytokines Drug Revenue Market Share by Country (2016-2026)
Figure 66. Europe Recombinant Cytokines Drug Sales Market Share by Type (2016-2026)
Figure 67. Europe Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Recombinant Cytokines Drug Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Recombinant Cytokines Drug Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Recombinant Cytokines Drug Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 72. South America Recombinant Cytokines Drug Sales Market Share by Country (2016-2026)
Figure 73. South America Recombinant Cytokines Drug Revenue Market Share by Country (2016-2026)
Figure 74. South America Recombinant Cytokines Drug Sales Market Share by Type (2016-2026)
Figure 75. South America Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Recombinant Cytokines Drug Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Recombinant Cytokines Drug Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Recombinant Cytokines Drug Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Recombinant Cytokines Drug Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の遺伝子組換え型ヒト顆粒球コロニー刺激因子市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Granulocyte Colony-Stimulating market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 世界の遺伝子組換え型ヒトトロンボポエチン（rhTPO）市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Thrombopoietin (rhTPO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の遺伝子組換え型ヒトインターフェロン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Interferon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の遺伝子組換え型ヒト卵胞刺激ホルモン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Follitropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の遺伝子組換え型ヒトインスリン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…